Viva Biotech Holdings (HKG:1873)
Hong Kong · Delayed Price · Currency is HKD 1.280
-0.050 (-3.76%)
Sep 11, 2026, 4:08 PM HKT
Viva Biotech Holdings Market Cap
Viva Biotech Holdings has a market cap or net worth of 2.74 billion as of September 11, 2026. Its market cap has decreased by -52.20% in one year.
Market Cap
2.74B
Enterprise Value
2.61B
Revenue
2.20B
Ranking
n/a
PE Ratio
16.74
Stock Price
1.28
ChartMarket Cap Chart
Since May 9, 2019, Viva Biotech Holdings's market cap has decreased from 6.63B to 2.74B, a decrease of -58.65%. That is a compound annual growth rate of -11.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 2.74B | -27.82% |
| Dec 31, 2025 | 3.80B | 109.02% |
| Dec 31, 2024 | 1.82B | -19.19% |
| Dec 29, 2023 | 2.25B | -32.91% |
| Dec 30, 2022 | 3.35B | -62.94% |
| Dec 31, 2021 | 9.04B | -48.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HJ Science | 3.02B |
| Jiangsu Recbio Technology | 3.02B |
| BioDlink International Company | 2.91B |
| Medtide | 2.82B |
| Beijing Luzhu Biotechnology | 2.71B |
| Laekna | 2.67B |
| Clover Biopharmaceuticals | 2.59B |
| Frontage Holdings | 2.40B |